Suppr超能文献

极晚期抗原1阻断显著促进同种异体角膜移植的存活。

Very late antigen 1 blockade markedly promotes survival of corneal allografts.

作者信息

Chen Lu, Huq Syed, Gardner Humphrey, de Fougerolles Antonin R, Barabino Stefano, Dana M Reza

机构信息

Laboratory of Immunology, Schepens Eye Research Institute and Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, 20 Staniford St, Boston, MA, USA.

出版信息

Arch Ophthalmol. 2007 Jun;125(6):783-8. doi: 10.1001/archopht.125.6.783.

Abstract

OBJECTIVE

To investigate the role of very late antigen 1 (VLA-1) (also known as integrin receptor alpha(1)beta(1)) in corneal transplantation inflammation and allograft survival.

METHODS

Cell infiltration and vasculogenesis (both angiogenesis and lymphangiogenesis) associated with allodisparate corneal transplantation were assessed in VLA-1-deficient conditions and controls by immunofluorescent microscopic studies. Corneal allograft survival was also assessed after anti-VLA-1 antibody treatment and in VLA-1 knockout recipient mice.

RESULTS

Anti-VLA-1 antibody treatment leads to a profound reduction in the granulocytic, monocytic, and T-cell infiltration after corneal transplantation. In addition, corneal angiogenesis and lymphangiogenesis were both significantly suppressed in VLA-1 knockout mice. Remarkably, universal graft survival was observed in both anti-VLA-1 antibody treatment and knockout mice.

CONCLUSIONS

Very late antigen 1 blockade markedly reduces inflammation and inflammation-induced tissue responses, including vasculogenic responses, associated with corneal transplantation and promotes allograft survival.

CLINICAL RELEVANCE

These studies offer insights into important integrin-mediated mechanisms of corneal transplant-related inflammation and provide possible new integrin-based immunotherapies for transplant rejection.

摘要

目的

研究极迟抗原1(VLA-1,也称为整合素受体α(1)β(1))在角膜移植炎症和同种异体移植存活中的作用。

方法

通过免疫荧光显微镜研究,在VLA-1缺陷条件下和对照中评估与异种角膜移植相关的细胞浸润和血管生成(包括血管生成和淋巴管生成)。在抗VLA-1抗体治疗后以及在VLA-1基因敲除受体小鼠中也评估了角膜同种异体移植的存活情况。

结果

抗VLA-1抗体治疗导致角膜移植后粒细胞、单核细胞和T细胞浸润显著减少。此外,VLA-1基因敲除小鼠的角膜血管生成和淋巴管生成均受到显著抑制。值得注意的是,在抗VLA-1抗体治疗组和基因敲除小鼠中均观察到移植普遍存活。

结论

极迟抗原1阻断可显著减轻与角膜移植相关的炎症以及炎症诱导的组织反应,包括血管生成反应,并促进同种异体移植存活。

临床意义

这些研究为整合素介导的角膜移植相关炎症的重要机制提供了见解,并为移植排斥反应提供了基于整合素的新型免疫治疗方法。

相似文献

1
Very late antigen 1 blockade markedly promotes survival of corneal allografts.
Arch Ophthalmol. 2007 Jun;125(6):783-8. doi: 10.1001/archopht.125.6.783.
2
Combined blockade of VEGFR-3 and VLA-1 markedly promotes high-risk corneal transplant survival.
Invest Ophthalmol Vis Sci. 2011 Aug 17;52(9):6529-35. doi: 10.1167/iovs.11-7454.
3
Soluble vascular endothelial growth factor receptor-3 suppresses allosensitization and promotes corneal allograft survival.
Graefes Arch Clin Exp Ophthalmol. 2014 Nov;252(11):1755-62. doi: 10.1007/s00417-014-2749-5. Epub 2014 Aug 5.
4
Very late antigen-1 mediates corneal lymphangiogenesis.
Invest Ophthalmol Vis Sci. 2011 Jul 1;52(7):4808-12. doi: 10.1167/iovs.10-6580.
6
The atypical chemokine receptor-2 does not alter corneal graft survival but regulates early stage of corneal graft-induced lymphangiogenesis.
Graefes Arch Clin Exp Ophthalmol. 2018 Oct;256(10):1875-1882. doi: 10.1007/s00417-018-4070-1. Epub 2018 Jul 27.
7
Kinetics of Angiogenic Responses in Corneal Transplantation.
Cornea. 2017 Apr;36(4):491-496. doi: 10.1097/ICO.0000000000001127.
8
Intracellular thiol redox status regulates lymphangiogenesis and dictates corneal limbal graft survival.
Invest Ophthalmol Vis Sci. 2010 May;51(5):2450-8. doi: 10.1167/iovs.09-4618. Epub 2009 Dec 30.
9
Deletion of the chemokine receptor CCR1 prolongs corneal allograft survival.
Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1228-36. doi: 10.1167/iovs.05-1483.
10
Angiopoietin-2 Blockade Promotes Survival of Corneal Transplants.
Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):79-86. doi: 10.1167/iovs.16-20485.

引用本文的文献

1
Biomechanical control of lymphatic vessel physiology and functions.
Cell Mol Immunol. 2023 Sep;20(9):1051-1062. doi: 10.1038/s41423-023-01042-9. Epub 2023 Jun 2.
2
Variable Responses to Corneal Grafts: Insights from Immunology and Systems Biology.
J Clin Med. 2020 Feb 21;9(2):586. doi: 10.3390/jcm9020586.
3
ALCAM Mediates DC Migration Through Afferent Lymphatics and Promotes Allospecific Immune Reactions.
Front Immunol. 2019 Apr 12;10:759. doi: 10.3389/fimmu.2019.00759. eCollection 2019.
4
Effector and Regulatory T Cell Trafficking in Corneal Allograft Rejection.
Mediators Inflamm. 2017;2017:8670280. doi: 10.1155/2017/8670280. Epub 2017 Apr 28.
5
Angiopoietin-2 Blockade Promotes Survival of Corneal Transplants.
Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):79-86. doi: 10.1167/iovs.16-20485.
6
Host immune cellular reactions in corneal neovascularization.
Int J Ophthalmol. 2016 Apr 18;9(4):625-33. doi: 10.18240/ijo.2016.04.25. eCollection 2016.
7
Integrin Alpha-9 Mediates Lymphatic Valve Formation in Corneal Lymphangiogenesis.
Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6313-9. doi: 10.1167/iovs.15-17509.
8
Integrin-dependent neutrophil migration in the injured mouse cornea.
Exp Eye Res. 2014 Mar;120:61-70. doi: 10.1016/j.exer.2014.01.004. Epub 2014 Jan 24.
9
Macrophage depletion impairs corneal wound healing after autologous transplantation in mice.
PLoS One. 2013 Apr 16;8(4):e61799. doi: 10.1371/journal.pone.0061799. Print 2013.
10
Dynamic structural changes are observed upon collagen and metal ion binding to the integrin α1 I domain.
J Biol Chem. 2012 Sep 21;287(39):32897-912. doi: 10.1074/jbc.M112.354365. Epub 2012 Jul 30.

本文引用的文献

1
Lymphangiogenesis in development and human disease.
Nature. 2005 Dec 15;438(7070):946-53. doi: 10.1038/nature04480.
2
Lymphatic system: unlocking the drains.
Nature. 2005 Jul 28;436(7050):456-8. doi: 10.1038/436456a.
3
The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1.
J Biol Chem. 2005 Feb 11;280(6):4544-52. doi: 10.1074/jbc.M412816200. Epub 2004 Dec 6.
4
The role of very late antigen-1 in immune-mediated inflammation.
Clin Immunol. 2004 Nov;113(2):119-29. doi: 10.1016/j.clim.2004.06.007.
6
Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity.
Nat Med. 2004 Aug;10(8):813-5. doi: 10.1038/nm1078. Epub 2004 Jul 4.
7
Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients.
Lupus. 2004;13(5):391-7. doi: 10.1191/0961203304lu1032oa.
9
Integrins: structure and signaling.
Biochemistry (Mosc). 2003 Dec;68(12):1284-99. doi: 10.1023/b:biry.0000011649.03634.74.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验